AIMP2 and PARP1

Will PARP inhibitors protect dopamine-making neurons in humans?

Will PARP inhibitors protect dopamine-making neurons in humans? These same drugs are currently undergoing clinical trials for breast, ovarian and colorectal cancer, and melanoma. There is reason to believe they may be helpful in Parkinson’s disease as well. Unfortunately, any clinical trials are a long way away.

posted on my Facebook page: Parkinson’s News

Annette

Annette

Annette is a fundraising consultant whose husband was recently diagnosed with Parkinson’s. Annette found a team of scientists working on a technology she thinks can stop Parkinson's. She was then able to raise funding for the project from multiple financial donors. And that's how Stop Parkinson's was born.
Annette

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>